Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Sachdev Amit
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   71,325    

Indirect Shares

  7,447      
Direct Value   $26,276,609    

Indirect Value

  $3,536,953      
Total Shares   78,772      
Total Value   $29,813,561      


Vertex Pharmaceuticals Inc
 $26,276,609 Celladon Corp
 $0 Vertex Pharmaceuticals Inc
 $26,276,609 Celladon Corp
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP Chief Patient & Ex... 2024-05-15 55,325 2024-05-15 7,447    Premium*  
            Celladon Corp CLDN 2022-03-11 16,000 2020-03-12 0    Premium*  
* Premium Members only  

Records found :    193         Free Registration Required For Full Results.    Limit: 25

Download
  Page 8 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-05-07 4 AS $52.13 $3,062,638 D/D (58,750) 31,108 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-02-11 4 AS $243.53 $3,216,311 D/D (13,070) 46,198 0 %
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-07-19 4 AS $161.00 $3,220,000 D/D (20,000) 99,335 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2013-07-12 4 AS $85.00 $3,225,000 D/D (37,500) 28,987 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2014-09-30 4 OE $33.28 $3,244,925 D/D 86,000 124,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2023-08-10 4 AS $350.00 $3,510,850 D/D (10,031) 58,814 0 %
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-03-29 4 OE $37.86 $3,576,273 D/D 80,500 179,835 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-05 4 AS $265.72 $3,606,232 D/D (13,356) 35,103 0 %
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-06-01 4 AS $125.00 $3,812,500 D/D (30,500) 99,335 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2014-06-24 4 AS $98.03 $4,141,768 D/D (42,250) 38,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-04 4 OE $86.52 $4,942,968 D/D 43,752 78,855 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2013-07-05 4 AS $80.65 $5,030,805 D/D (61,907) 28,987 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-01-19 4 AS $157.67 $5,125,400 D/D (32,422) 39,163 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-10-31 4 AS $142.40 $5,802,084 D/D (40,000) 50,710 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2019-02-11 4 AS $179.44 $6,319,216 D/D (35,095) 40,165 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-03-29 4 AS $106.30 $8,664,568 D/D (80,500) 99,335 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2014-09-30 4 AS $111.33 $9,690,570 D/D (86,000) 38,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-04 4 AS $258.59 $11,475,179 D/D (43,752) 35,103 0 %

  193  Records found
  1   2   3   4   5   6   7   8     
  Page 8 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed